- Yale Pediatric Hematology/OncologySmilow Cancer Hospital at Yale New Haven35 Park Street, Fl 7New Haven, CT 06511
- YNHCH Pediatric Specialty Center at TrumbullTrumbull Pediatric Specialty Center5520 Park Avenue, Ste 600Trumbull, CT 06611
Asher Marks, MD
Biography
Asher Marks, MD, is a Yale Medicine hematologist and oncologist and director of Pediatric Neuro-Oncology. He is also the director of the adolescent and young adult (AYA) cancer program for Yale New Haven Children’s Hospital.
“Adolescence is tough to begin with in terms of development, finding yourself, and fitting in with your peers,” says Dr. Marks. “And when adolescents are diagnosed with cancer, at the hospital, they will often self-isolate. They don't want to come out of the room. They just want to kind of be alone and do their thing.”
That’s what drove Dr. Marks to help create the Lauren Telesz/Smilow Teen Center. Having peers in similar situations, he says, gives teens and young adults a support network that can help them through treatment. “We know that psycho-social support is one of the most, if not the most important thing, for this population. So, we really focus on that,” he says.
Dr. Marks, who is an assistant professor of pediatrics (hematology/oncology) at Yale School of Medicine, is working on clinical trials to help find new treatments for tumors in adolescents and young adults. “Most clinical trials are not designed for them,” says Dr. Marks. He and his colleagues hope to change that by offering clinical trials for them to help improve survival rates.
“We have a very robust team looking to care for adolescents,” he says.
Titles
- Associate Professor of Pediatrics (Hematology/Oncology)
- Director, Pediatric Neuro-Oncology
Education & Training
- FellowshipChildren's National Medical Center (2013)
- FellowshipChildren's National Medical Center (2012)
- ResidencyChildren's National Medical Center (2009)
- MDTemple University School of Medicine (2006)
- BSPennsylvania State University, Premedicine and Religious Studies (2002)
Additional Information
- AB of Pediatrics, Pediatric Hematology-Oncology (2015)
- Roberts S, Havill N, Flores RM, Hendrix C, Williams MJ, Feinn RS, Choi SJ, Martinello RA, Marks AM, Murray TS. Disinfection of Virtual Reality Devices in Health Care Settings: In Vitro Assessment and Survey Study. Journal Of Medical Internet Research 2022, 24: e42332. PMID: 36269222, PMCID: PMC9756115, DOI: 10.2196/42332.
- Marks A, Antaya R, Balsamo L, Cardinale K, Cheron R, Frumberg D, Gentile V, Habib L, Puthenpura V, Zhang H. NFB-05. A family-centered neurocutaneous syndrome clinic in the age of targeted therapies. Neuro-Oncology 2022, 24: i129-i129. PMCID: PMC9165028, DOI: 10.1093/neuonc/noac079.469.
- Puthenpura V, DeNunzio NJ, Zeng X, Giantsoudi D, Aboian M, Ebb D, Kahle KT, Yock TI, Marks AM. Radiation Necrosis with Proton Therapy in a Patient with Aarskog-Scott Syndrome and Medulloblastoma. International Journal Of Particle Therapy 2021, 8: 58-65. PMID: 35127977, PMCID: PMC8768897, DOI: 10.14338/ijpt-21-00013.1.
- Puthenpura V, Canavan ME, Poynter JN, Roth M, Pashankar FD, Jones BA, Marks AM. Racial/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors. Pediatric Blood & Cancer 2021, 68: e28970. PMID: 33704901, PMCID: PMC8221084, DOI: 10.1002/pbc.28970.
- Puthenpura V, Marks AM. Clinical Application of Digital Technologies in Adolescent and Young Adult Oncology Supportive Care. Journal Of Adolescent And Young Adult Oncology 2020, 10: 127-130. PMID: 33296259, PMCID: PMC8182471, DOI: 10.1089/jayao.2020.0153.
- Hieftje K, Marks A, Schartmann A. Year of the Cicadas: Using Sound and Story to Understand Parental Grief. 2025, 00: 927-928. DOI: 10.1109/ismar-adjunct68609.2025.00287.
- Truesdell E, Weser V, Murray T, Crocker A, Marks A, Martinello R, Hieftje K. Game Playbooks 2.0: An Updated Strategy for Supporting Game-Based Behavior Change Interventions. Proceedings Of The ACM On Human-Computer Interaction 2025, 9: 1021-1044. DOI: 10.1145/3748631.
- Roberts S, Wright J, Mustafa M, Feinn R, Marks A, Hieftje K, Huang P, Martinello R, Murray T, Blake E, Trumpler J, Frye N, Nilsen E, Paek H, Boyce M, Mayeran C, Polcaro T, Hallet A, Greene-Upshaw L, Kashyap N, Peaper D, Evans L, Weser V, Truesdell E, Crocker A, Tanner W, Peccia J, Dieter L, Healy H, Mathew T. Bactericidal Efficacy of Ultraviolet-C Light on Virtual Reality Devices: In Vitro Assessment of Bacterial Killing. JMIR Formative Research 2025, 9: e70326. PMID: 41038799, PMCID: PMC12483473, DOI: 10.2196/70326.
- Murray T, Shenoy E, Roberts S, Martinello R, Marks A, Hieftje K, Green C, Rothschild J, Shradar M, McKinney T, Hand L, Novosad S, Glowicz J. Applying principles to practice: cleaning and disinfection of extended reality equipment used in healthcare settings. Infection Control And Hospital Epidemiology 2025, 46: 855-857. PMID: 40826908, DOI: 10.1017/ice.2025.10249.
- Puthenpura V, Hunter M, Marks A. “Techquity” in Pediatric, Adolescent, and Young Adult Oncology: Addressing Inequities Through Artificial Intelligence and Immersive Technologies. Pediatric Blood & Cancer 2025, 72: e31909. PMID: 40879575, DOI: 10.1002/pbc.31909.
- Berry J, Gancz M, Marks A, Hieftje K. Lemmings: Creating Re-mappable Gestures For More Accessible Immersive Experiences. 2025, 441-446. DOI: 10.1145/3706370.3732894.
- Wei S, Lee B, Gancz M, Marks A, Hieftje K. The Arborist: A Collective Bloom Through Physiological Data in Mixed Reality. 2025, 364-367. DOI: 10.1145/3706370.3731714.
- Gancz M, Berry J, Wei S, Hieftje K, Marks A. Demonstrating the Screenless Optical Theremin with Tremolo (ScOTT). 2025, 329-332. DOI: 10.1145/3706370.3731699.
- Marks A, Weser V, Caruso T, Persky S, Homer A, Gold J, Williamson E, Hieftje K. AMXRA Guidelines on Extended Reality (XR) and Children: Considerations for Safe and Effective Application Development and Use. Journal Of Medical Extended Reality 2025, 2: 104-113. PMID: 40862272, PMCID: PMC12373118.
- Weser V, Crocker A, Murray T, Wright J, Truesdell E, Ciaburri R, Marks A, Martinello R, Hieftje K, Team H. Barriers to Effective Infection Prevention in the Neonatal Intensive Care Unit. Advances In Neonatal Care 2024, 24: 475-484. PMID: 39196970, DOI: 10.1097/anc.0000000000001195.
- Hieftje K, Marks A. Player 2 Has Entered the Game: Extended Reality and Games for Health. Games For Health Journal 2023, 12: 427-428. PMID: 38048478, DOI: 10.1089/g4h.2023.0215.
- Marks A, Garbatini A, Hieftje K, Puthenpura V, Weser V, Fernandes C. Use of Immersive Virtual Reality Spaces to Engage Adolescent and Young Adult Patients With Cancer in Therapist-Guided Support Groups: Protocol for a Pre-Post Study. JMIR Research Protocols 2023, 12: e48761. PMID: 37943596, PMCID: PMC10667982, DOI: 10.2196/48761.
- The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancerAl Assaad M, Gundem G, Liechty B, Sboner A, Medina J, Papaemmanuil E, Sternberg C, Marks A, Souweidane M, Greenfield J, Tran I, Snuderl M, Elemento O, Imielinski M, Pisapia D, Mosquera J. The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer. Molecular Case Studies 2023, 9: a006275. PMID: 37652664, PMCID: PMC10815291, DOI: 10.1101/mcs.a006275.
- Puthenpura V, Bona K, Cooney T, Coven S, Davidson T, Fouladi M, Kline C, Leary S, Mueller S, Green A, Marks A. OUTC-08. IMPLEMENTING SOCIAL DETERMINANT OF HEALTH DATA COLLECTION FOR PEDIATRIC, ADOLESCENT AND YOUNG ADULT NEURO-ONCOLOGY PATIENTS IN THE CLINICAL TRIAL CONSORTIA SETTING: PROGRESS AND CHALLENGES. Neuro-Oncology 2023, 25: i37-i37. PMCID: PMC10260067, DOI: 10.1093/neuonc/noad073.145.
- Puthenpura V, Nadkarni S, DiLuna M, Hieftje K, Marks A. Personality Changes and Staring Spells in a 12-Year-Old Child: A Case Report Incorporating ChatGPT, a Natural Language Processing Tool Driven by Artificial Intelligence (AI). Cureus 2023, 15: e36408. PMID: 37090271, PMCID: PMC10115215, DOI: 10.7759/cureus.36408.
- Puthenpura V, Ji L, Xu X, Roth M, Freyer D, Frazier A, Marks A, Pashankar F. Loss to follow‐up of minorities, adolescents, and young adults on clinical trials: A report from the Children's Oncology Group. Cancer 2023, 129: 1547-1556. PMID: 36813754, PMCID: PMC10357561, DOI: 10.1002/cncr.34701.
- Fadel SA, von Reppert M, Kazarian E, Omay EZE, Marks A, Linder N, Hoffmann KT, Darbinyan A, Huttner A, Aboian MS. Spectrum of qualitative and quantitative imaging of pilomyxoid, intermediate pilomyxoid and pilocytic astrocytomas in relation to their genetic alterations. Neuroradiology 2022, 65: 195-205. PMID: 35984480, DOI: 10.1007/s00234-022-03027-3.
- Marks A, Bindra R. CLRM-03. BGB-290 AND TEMOZOLOMIDE IN TREATING ISOCITRATE DEHYDROGENASE (IDH)1/2-MUTANT GRADE I-IV GLIOMAS – A NOVEL MODEL OF AYA TRIAL DEVELOPMENT AND DEPLOYMENT. Neuro-Oncology Advances 2021, 3: iv1-iv1. PMCID: PMC8453774, DOI: 10.1093/noajnl/vdab112.002.
- Kazarian E, Marks A, Cui J, Darbinyan A, Tong E, Mueller S, Cha S, Aboian MS. Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas. Scientific Reports 2021, 11: 14377. PMID: 34257334, PMCID: PMC8277861, DOI: 10.1038/s41598-021-92943-0.
- Fomchenko EI, Reeves BC, Sullivan W, Marks AM, Huttner A, Kahle KT, Erson‐Omay E. Dual activating FGFR1 mutations in pediatric pilomyxoid astrocytoma. Molecular Genetics & Genomic Medicine 2021, 9: e1597. PMID: 33448156, PMCID: PMC8077124, DOI: 10.1002/mgg3.1597.
- Hong CS, Vasquez JC, Kundishora AJ, Elsamadicy AA, Beckta JM, Sule A, Marks AM, Leelatian N, Huttner A, Bindra RS, DiLuna ML, Kahle KT, Erson-Omay EZ. Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma. Npj Genomic Medicine 2020, 5: 23. PMID: 32528726, PMCID: PMC7264170, DOI: 10.1038/s41525-020-0130-7.
- Abi Fadel S, Erson Omay Z, Darbinyan A, Marks A, Bronen R, Fulbright R, Mahajan A, Aboian M. Correlating genetic signature of pilomyxoid astrocytomas and pilocytic astrocytomas with qualitative and quantitative MR imaging characteristics. 2020 DOI: 10.26226/morressier.5e8335ba7cb08a046ef7c7e5.
- Fomchenko EI, Erson-Omay EZ, Kundishora AJ, Hong CS, Daniel AA, Allocco A, Duy PQ, Darbinyan A, Marks AM, DiLuna ML, Kahle KT, Huttner A. Genomic alterations underlying spinal metastases in pediatric H3K27M-mutant pineal parenchymal tumor of intermediate differentiation: case report. Journal Of Neurosurgery Pediatrics 2019, 25: 121-130. PMID: 31653819, DOI: 10.3171/2019.8.peds18664.
- Hong C, Kundishora A, Fomchenko E, Huttner A, Erson-Omay Z, Marks A, Diluna M, Kahle K. HGG-01. ACQUISITION OF A HYPERMUTATOR PHENOTYPE UNDERLYING DISTANT SPINAL INTRAMEDULLARY SPREAD IN HISTONE-MUTATED DIFFUSE MIDLINE GLIOMA. Neuro-Oncology 2019, 21: ii86-ii86. PMCID: PMC6477387, DOI: 10.1093/neuonc/noz036.095.
- Hong C, Kundishora A, Omay E, Huttner A, Marks A, Diluna M, Kahle K. PDTM-35. GENETIC ALTERATIONS DRIVING SPINAL INTRAMEDULLARY METASTASES OF A HISTONE-MUTATED DIFFUSE MIDLINE PINEAL GLIOMA. Neuro-Oncology 2018, 20: vi211-vi211. PMCID: PMC6217703, DOI: 10.1093/neuonc/noy148.875.
- Wu X, Subtil A, Craiglow B, Watsky K, Marks A, Ko C. The coexistence of lupus erythematosus panniculitis and subcutaneous panniculitislike T-cell lymphoma in the same patient. JAAD Case Reports 2018, 4: 179-184. PMID: 29892661, PMCID: PMC5993551, DOI: 10.1016/j.jdcr.2017.08.021.
- Marks AM, Bindra RS, DiLuna ML, Huttner A, Jairam V, Kahle KT, Kieran MW. Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib. Pediatric Blood & Cancer 2018, 65: e26969. PMID: 29380516, DOI: 10.1002/pbc.26969.
- Bornhorst M, Goecks J, Boue D, Broniscer A, Hwang E, Koschmann C, Marks A, Mody R, Mueller S, Orr B, Packer R, Solomon D, Turner J, Vortmeyer A, Nazarian J, Ho C. PDTM-25. GENETIC SUSCEPTIBILITY AND EVOLUTION OF PEDIATRIC IDH-MUTANT INFILTRATING ASTROCYTOMAS. Neuro-Oncology 2017, 19: vi195-vi195. PMCID: PMC5692642, DOI: 10.1093/neuonc/nox168.789.
- Yoder N, Marks A, Hui P, Litkouhi B, Cron J. Low-Grade Astrocytoma within a Mature Cystic Teratoma in an Adolescent Patient. Journal Of Pediatric And Adolescent Gynecology 2017, 31: 325-327. PMID: 29107097, DOI: 10.1016/j.jpag.2017.10.005.
- Vasquez JC, Huttner A, Zhang L, Marks A, Chan A, Baehring JM, Kahle KT, Dhodapkar KM. SOX2 immunity and tissue resident memory in children and young adults with glioma. Journal Of Neuro-Oncology 2017, 134: 41-53. PMID: 28620836, PMCID: PMC7906294, DOI: 10.1007/s11060-017-2515-8.
- Vasquez J, Huttner A, Zhang L, Marks A, Chan A, Baehring J, Kahle K, Dhodapkar K. SOX2 as a target for immunotherapy of pediatric gliomas. Journal Of Clinical Oncology 2017, 35: e22012-e22012. DOI: 10.1200/jco.2017.35.15_suppl.e22012.
- Yoder N, Marks A, Hui P, Litkouhi B, Cron J. Low-Grade Astrocytoma Within a Mature Cystic Teratoma in an Adolescent Patient: A Case Report. Journal Of Pediatric And Adolescent Gynecology 2017, 30: 295. DOI: 10.1016/j.jpag.2017.03.059.
- Kann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Khan AJ, Bindra RS, Marks AM, Roberts KB. Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children. JAMA Oncology 2016, 2: 1574-1581. PMID: 27491009, DOI: 10.1001/jamaoncol.2016.2547.
- Kann B, Park H, Lester-Coll N, Yeboa D, Benitez V, Bindra R, Khan A, Marks A, Roberts K. Adjuvant Radiation Therapy Patterns and Survival Implications for Medulloblastoma in Young Children. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s230-s231. DOI: 10.1016/j.ijrobp.2016.06.573.
- Lucchesi KM, Grant R, Kahle KT, Marks AM, DiLuna ML. Primary spinal myxopapillary ependymoma in the pediatric population: a study from the Surveillance, Epidemiology, and End Results (SEER) database. Journal Of Neuro-Oncology 2016, 130: 133-140. PMID: 27423644, DOI: 10.1007/s11060-016-2218-6.
- Kann B, Park H, Lester-Coll N, Yeboa D, Benitez V, Bindra R, Khan A, Marks A, Roberts K. MB-38ADJUVANT RADIOTHERAPY PATTERNS OF CARE AND SURVIVAL IMPLICATIONS FOR MEDULLOBLASTOMA IN YOUNG CHILDREN. Neuro-Oncology 2016, 18: iii105-iii105. PMCID: PMC4903595, DOI: 10.1093/neuonc/now076.36.
- Lucchesi K, Grant R, Marks A, DiLuna M. Spinal Myxopapillary Ependymomas in Children and Young Adults: A Population-Based Study (P3.275). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.p3.275.
- Alomari AK, Kelley BJ, Damisah E, Marks A, Hui P, DiLuna M, Vortmeyer A. Craniopharyngioma arising in a Rathke's cleft cyst: case report. Journal Of Neurosurgery Pediatrics 2015, 15: 250-4. PMID: 25555112, DOI: 10.3171/2014.11.peds14370.
- Marks A, Luo H, Chui DH, Greenberg J. Hemoglobin shady grove: A novel fetal methemoglobin variant. Pediatric Blood & Cancer 2013, 60: e55-e56. PMID: 23460588, DOI: 10.1002/pbc.24503.
- Marks AM, Packer RJ. A Review of Secondary Central Nervous System Tumors After Treatment of a Primary Pediatric Malignancy. Seminars In Pediatric Neurology 2012, 19: 43-48. PMID: 22641075, DOI: 10.1016/j.spen.2012.02.015.
- Maniscalco J, Dryer A, Marks A, Yunghans M. Index of Suspicion. Pediatrics In Review 2008, 29: 321-328. DOI: 10.1542/pir.29.9.321.
- Maniscalco J, Dryer AL, Marks A, Yunghans M, Pierson SB, Sgarlat CM, Sveen AR, Blanch LE. Index of Suspicion. Pediatrics In Review 2008, 29: 321-328. PMID: 18765471, DOI: 10.1542/pir.29-9-321.
- Yale Pediatric Hematology/OncologySmilow Cancer Hospital at Yale New Haven35 Park Street, Fl 7New Haven, CT 06511
- YNHCH Pediatric Specialty Center at TrumbullTrumbull Pediatric Specialty Center5520 Park Avenue, Ste 600Trumbull, CT 06611
Biography
Asher Marks, MD, is a Yale Medicine hematologist and oncologist and director of Pediatric Neuro-Oncology. He is also the director of the adolescent and young adult (AYA) cancer program for Yale New Haven Children’s Hospital.
“Adolescence is tough to begin with in terms of development, finding yourself, and fitting in with your peers,” says Dr. Marks. “And when adolescents are diagnosed with cancer, at the hospital, they will often self-isolate. They don't want to come out of the room. They just want to kind of be alone and do their thing.”
That’s what drove Dr. Marks to help create the Lauren Telesz/Smilow Teen Center. Having peers in similar situations, he says, gives teens and young adults a support network that can help them through treatment. “We know that psycho-social support is one of the most, if not the most important thing, for this population. So, we really focus on that,” he says.
Dr. Marks, who is an assistant professor of pediatrics (hematology/oncology) at Yale School of Medicine, is working on clinical trials to help find new treatments for tumors in adolescents and young adults. “Most clinical trials are not designed for them,” says Dr. Marks. He and his colleagues hope to change that by offering clinical trials for them to help improve survival rates.
“We have a very robust team looking to care for adolescents,” he says.
Titles
- Associate Professor of Pediatrics (Hematology/Oncology)
- Director, Pediatric Neuro-Oncology
Education & Training
- FellowshipChildren's National Medical Center (2013)
- FellowshipChildren's National Medical Center (2012)
- ResidencyChildren's National Medical Center (2009)
- MDTemple University School of Medicine (2006)
- BSPennsylvania State University, Premedicine and Religious Studies (2002)
Additional Information
- AB of Pediatrics, Pediatric Hematology-Oncology (2015)
- Roberts S, Havill N, Flores RM, Hendrix C, Williams MJ, Feinn RS, Choi SJ, Martinello RA, Marks AM, Murray TS. Disinfection of Virtual Reality Devices in Health Care Settings: In Vitro Assessment and Survey Study. Journal Of Medical Internet Research 2022, 24: e42332. PMID: 36269222, PMCID: PMC9756115, DOI: 10.2196/42332.
- Marks A, Antaya R, Balsamo L, Cardinale K, Cheron R, Frumberg D, Gentile V, Habib L, Puthenpura V, Zhang H. NFB-05. A family-centered neurocutaneous syndrome clinic in the age of targeted therapies. Neuro-Oncology 2022, 24: i129-i129. PMCID: PMC9165028, DOI: 10.1093/neuonc/noac079.469.
- Puthenpura V, DeNunzio NJ, Zeng X, Giantsoudi D, Aboian M, Ebb D, Kahle KT, Yock TI, Marks AM. Radiation Necrosis with Proton Therapy in a Patient with Aarskog-Scott Syndrome and Medulloblastoma. International Journal Of Particle Therapy 2021, 8: 58-65. PMID: 35127977, PMCID: PMC8768897, DOI: 10.14338/ijpt-21-00013.1.
- Puthenpura V, Canavan ME, Poynter JN, Roth M, Pashankar FD, Jones BA, Marks AM. Racial/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors. Pediatric Blood & Cancer 2021, 68: e28970. PMID: 33704901, PMCID: PMC8221084, DOI: 10.1002/pbc.28970.
- Puthenpura V, Marks AM. Clinical Application of Digital Technologies in Adolescent and Young Adult Oncology Supportive Care. Journal Of Adolescent And Young Adult Oncology 2020, 10: 127-130. PMID: 33296259, PMCID: PMC8182471, DOI: 10.1089/jayao.2020.0153.
- Hieftje K, Marks A, Schartmann A. Year of the Cicadas: Using Sound and Story to Understand Parental Grief. 2025, 00: 927-928. DOI: 10.1109/ismar-adjunct68609.2025.00287.
- Truesdell E, Weser V, Murray T, Crocker A, Marks A, Martinello R, Hieftje K. Game Playbooks 2.0: An Updated Strategy for Supporting Game-Based Behavior Change Interventions. Proceedings Of The ACM On Human-Computer Interaction 2025, 9: 1021-1044. DOI: 10.1145/3748631.
- Roberts S, Wright J, Mustafa M, Feinn R, Marks A, Hieftje K, Huang P, Martinello R, Murray T, Blake E, Trumpler J, Frye N, Nilsen E, Paek H, Boyce M, Mayeran C, Polcaro T, Hallet A, Greene-Upshaw L, Kashyap N, Peaper D, Evans L, Weser V, Truesdell E, Crocker A, Tanner W, Peccia J, Dieter L, Healy H, Mathew T. Bactericidal Efficacy of Ultraviolet-C Light on Virtual Reality Devices: In Vitro Assessment of Bacterial Killing. JMIR Formative Research 2025, 9: e70326. PMID: 41038799, PMCID: PMC12483473, DOI: 10.2196/70326.
- Murray T, Shenoy E, Roberts S, Martinello R, Marks A, Hieftje K, Green C, Rothschild J, Shradar M, McKinney T, Hand L, Novosad S, Glowicz J. Applying principles to practice: cleaning and disinfection of extended reality equipment used in healthcare settings. Infection Control And Hospital Epidemiology 2025, 46: 855-857. PMID: 40826908, DOI: 10.1017/ice.2025.10249.
- Puthenpura V, Hunter M, Marks A. “Techquity” in Pediatric, Adolescent, and Young Adult Oncology: Addressing Inequities Through Artificial Intelligence and Immersive Technologies. Pediatric Blood & Cancer 2025, 72: e31909. PMID: 40879575, DOI: 10.1002/pbc.31909.
- Berry J, Gancz M, Marks A, Hieftje K. Lemmings: Creating Re-mappable Gestures For More Accessible Immersive Experiences. 2025, 441-446. DOI: 10.1145/3706370.3732894.
- Wei S, Lee B, Gancz M, Marks A, Hieftje K. The Arborist: A Collective Bloom Through Physiological Data in Mixed Reality. 2025, 364-367. DOI: 10.1145/3706370.3731714.
- Gancz M, Berry J, Wei S, Hieftje K, Marks A. Demonstrating the Screenless Optical Theremin with Tremolo (ScOTT). 2025, 329-332. DOI: 10.1145/3706370.3731699.
- Marks A, Weser V, Caruso T, Persky S, Homer A, Gold J, Williamson E, Hieftje K. AMXRA Guidelines on Extended Reality (XR) and Children: Considerations for Safe and Effective Application Development and Use. Journal Of Medical Extended Reality 2025, 2: 104-113. PMID: 40862272, PMCID: PMC12373118.
- Weser V, Crocker A, Murray T, Wright J, Truesdell E, Ciaburri R, Marks A, Martinello R, Hieftje K, Team H. Barriers to Effective Infection Prevention in the Neonatal Intensive Care Unit. Advances In Neonatal Care 2024, 24: 475-484. PMID: 39196970, DOI: 10.1097/anc.0000000000001195.
- Hieftje K, Marks A. Player 2 Has Entered the Game: Extended Reality and Games for Health. Games For Health Journal 2023, 12: 427-428. PMID: 38048478, DOI: 10.1089/g4h.2023.0215.
- Marks A, Garbatini A, Hieftje K, Puthenpura V, Weser V, Fernandes C. Use of Immersive Virtual Reality Spaces to Engage Adolescent and Young Adult Patients With Cancer in Therapist-Guided Support Groups: Protocol for a Pre-Post Study. JMIR Research Protocols 2023, 12: e48761. PMID: 37943596, PMCID: PMC10667982, DOI: 10.2196/48761.
- The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancerAl Assaad M, Gundem G, Liechty B, Sboner A, Medina J, Papaemmanuil E, Sternberg C, Marks A, Souweidane M, Greenfield J, Tran I, Snuderl M, Elemento O, Imielinski M, Pisapia D, Mosquera J. The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer. Molecular Case Studies 2023, 9: a006275. PMID: 37652664, PMCID: PMC10815291, DOI: 10.1101/mcs.a006275.
- Puthenpura V, Bona K, Cooney T, Coven S, Davidson T, Fouladi M, Kline C, Leary S, Mueller S, Green A, Marks A. OUTC-08. IMPLEMENTING SOCIAL DETERMINANT OF HEALTH DATA COLLECTION FOR PEDIATRIC, ADOLESCENT AND YOUNG ADULT NEURO-ONCOLOGY PATIENTS IN THE CLINICAL TRIAL CONSORTIA SETTING: PROGRESS AND CHALLENGES. Neuro-Oncology 2023, 25: i37-i37. PMCID: PMC10260067, DOI: 10.1093/neuonc/noad073.145.
- Puthenpura V, Nadkarni S, DiLuna M, Hieftje K, Marks A. Personality Changes and Staring Spells in a 12-Year-Old Child: A Case Report Incorporating ChatGPT, a Natural Language Processing Tool Driven by Artificial Intelligence (AI). Cureus 2023, 15: e36408. PMID: 37090271, PMCID: PMC10115215, DOI: 10.7759/cureus.36408.
- Puthenpura V, Ji L, Xu X, Roth M, Freyer D, Frazier A, Marks A, Pashankar F. Loss to follow‐up of minorities, adolescents, and young adults on clinical trials: A report from the Children's Oncology Group. Cancer 2023, 129: 1547-1556. PMID: 36813754, PMCID: PMC10357561, DOI: 10.1002/cncr.34701.
- Fadel SA, von Reppert M, Kazarian E, Omay EZE, Marks A, Linder N, Hoffmann KT, Darbinyan A, Huttner A, Aboian MS. Spectrum of qualitative and quantitative imaging of pilomyxoid, intermediate pilomyxoid and pilocytic astrocytomas in relation to their genetic alterations. Neuroradiology 2022, 65: 195-205. PMID: 35984480, DOI: 10.1007/s00234-022-03027-3.
- Marks A, Bindra R. CLRM-03. BGB-290 AND TEMOZOLOMIDE IN TREATING ISOCITRATE DEHYDROGENASE (IDH)1/2-MUTANT GRADE I-IV GLIOMAS – A NOVEL MODEL OF AYA TRIAL DEVELOPMENT AND DEPLOYMENT. Neuro-Oncology Advances 2021, 3: iv1-iv1. PMCID: PMC8453774, DOI: 10.1093/noajnl/vdab112.002.
- Kazarian E, Marks A, Cui J, Darbinyan A, Tong E, Mueller S, Cha S, Aboian MS. Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas. Scientific Reports 2021, 11: 14377. PMID: 34257334, PMCID: PMC8277861, DOI: 10.1038/s41598-021-92943-0.
- Fomchenko EI, Reeves BC, Sullivan W, Marks AM, Huttner A, Kahle KT, Erson‐Omay E. Dual activating FGFR1 mutations in pediatric pilomyxoid astrocytoma. Molecular Genetics & Genomic Medicine 2021, 9: e1597. PMID: 33448156, PMCID: PMC8077124, DOI: 10.1002/mgg3.1597.
- Hong CS, Vasquez JC, Kundishora AJ, Elsamadicy AA, Beckta JM, Sule A, Marks AM, Leelatian N, Huttner A, Bindra RS, DiLuna ML, Kahle KT, Erson-Omay EZ. Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma. Npj Genomic Medicine 2020, 5: 23. PMID: 32528726, PMCID: PMC7264170, DOI: 10.1038/s41525-020-0130-7.
- Abi Fadel S, Erson Omay Z, Darbinyan A, Marks A, Bronen R, Fulbright R, Mahajan A, Aboian M. Correlating genetic signature of pilomyxoid astrocytomas and pilocytic astrocytomas with qualitative and quantitative MR imaging characteristics. 2020 DOI: 10.26226/morressier.5e8335ba7cb08a046ef7c7e5.
- Fomchenko EI, Erson-Omay EZ, Kundishora AJ, Hong CS, Daniel AA, Allocco A, Duy PQ, Darbinyan A, Marks AM, DiLuna ML, Kahle KT, Huttner A. Genomic alterations underlying spinal metastases in pediatric H3K27M-mutant pineal parenchymal tumor of intermediate differentiation: case report. Journal Of Neurosurgery Pediatrics 2019, 25: 121-130. PMID: 31653819, DOI: 10.3171/2019.8.peds18664.
- Hong C, Kundishora A, Fomchenko E, Huttner A, Erson-Omay Z, Marks A, Diluna M, Kahle K. HGG-01. ACQUISITION OF A HYPERMUTATOR PHENOTYPE UNDERLYING DISTANT SPINAL INTRAMEDULLARY SPREAD IN HISTONE-MUTATED DIFFUSE MIDLINE GLIOMA. Neuro-Oncology 2019, 21: ii86-ii86. PMCID: PMC6477387, DOI: 10.1093/neuonc/noz036.095.
- Hong C, Kundishora A, Omay E, Huttner A, Marks A, Diluna M, Kahle K. PDTM-35. GENETIC ALTERATIONS DRIVING SPINAL INTRAMEDULLARY METASTASES OF A HISTONE-MUTATED DIFFUSE MIDLINE PINEAL GLIOMA. Neuro-Oncology 2018, 20: vi211-vi211. PMCID: PMC6217703, DOI: 10.1093/neuonc/noy148.875.
- Wu X, Subtil A, Craiglow B, Watsky K, Marks A, Ko C. The coexistence of lupus erythematosus panniculitis and subcutaneous panniculitislike T-cell lymphoma in the same patient. JAAD Case Reports 2018, 4: 179-184. PMID: 29892661, PMCID: PMC5993551, DOI: 10.1016/j.jdcr.2017.08.021.
- Marks AM, Bindra RS, DiLuna ML, Huttner A, Jairam V, Kahle KT, Kieran MW. Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib. Pediatric Blood & Cancer 2018, 65: e26969. PMID: 29380516, DOI: 10.1002/pbc.26969.
- Bornhorst M, Goecks J, Boue D, Broniscer A, Hwang E, Koschmann C, Marks A, Mody R, Mueller S, Orr B, Packer R, Solomon D, Turner J, Vortmeyer A, Nazarian J, Ho C. PDTM-25. GENETIC SUSCEPTIBILITY AND EVOLUTION OF PEDIATRIC IDH-MUTANT INFILTRATING ASTROCYTOMAS. Neuro-Oncology 2017, 19: vi195-vi195. PMCID: PMC5692642, DOI: 10.1093/neuonc/nox168.789.
- Yoder N, Marks A, Hui P, Litkouhi B, Cron J. Low-Grade Astrocytoma within a Mature Cystic Teratoma in an Adolescent Patient. Journal Of Pediatric And Adolescent Gynecology 2017, 31: 325-327. PMID: 29107097, DOI: 10.1016/j.jpag.2017.10.005.
- Vasquez JC, Huttner A, Zhang L, Marks A, Chan A, Baehring JM, Kahle KT, Dhodapkar KM. SOX2 immunity and tissue resident memory in children and young adults with glioma. Journal Of Neuro-Oncology 2017, 134: 41-53. PMID: 28620836, PMCID: PMC7906294, DOI: 10.1007/s11060-017-2515-8.
- Vasquez J, Huttner A, Zhang L, Marks A, Chan A, Baehring J, Kahle K, Dhodapkar K. SOX2 as a target for immunotherapy of pediatric gliomas. Journal Of Clinical Oncology 2017, 35: e22012-e22012. DOI: 10.1200/jco.2017.35.15_suppl.e22012.
- Yoder N, Marks A, Hui P, Litkouhi B, Cron J. Low-Grade Astrocytoma Within a Mature Cystic Teratoma in an Adolescent Patient: A Case Report. Journal Of Pediatric And Adolescent Gynecology 2017, 30: 295. DOI: 10.1016/j.jpag.2017.03.059.
- Kann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Khan AJ, Bindra RS, Marks AM, Roberts KB. Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children. JAMA Oncology 2016, 2: 1574-1581. PMID: 27491009, DOI: 10.1001/jamaoncol.2016.2547.
- Kann B, Park H, Lester-Coll N, Yeboa D, Benitez V, Bindra R, Khan A, Marks A, Roberts K. Adjuvant Radiation Therapy Patterns and Survival Implications for Medulloblastoma in Young Children. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s230-s231. DOI: 10.1016/j.ijrobp.2016.06.573.
- Lucchesi KM, Grant R, Kahle KT, Marks AM, DiLuna ML. Primary spinal myxopapillary ependymoma in the pediatric population: a study from the Surveillance, Epidemiology, and End Results (SEER) database. Journal Of Neuro-Oncology 2016, 130: 133-140. PMID: 27423644, DOI: 10.1007/s11060-016-2218-6.
- Kann B, Park H, Lester-Coll N, Yeboa D, Benitez V, Bindra R, Khan A, Marks A, Roberts K. MB-38ADJUVANT RADIOTHERAPY PATTERNS OF CARE AND SURVIVAL IMPLICATIONS FOR MEDULLOBLASTOMA IN YOUNG CHILDREN. Neuro-Oncology 2016, 18: iii105-iii105. PMCID: PMC4903595, DOI: 10.1093/neuonc/now076.36.
- Lucchesi K, Grant R, Marks A, DiLuna M. Spinal Myxopapillary Ependymomas in Children and Young Adults: A Population-Based Study (P3.275). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.p3.275.
- Alomari AK, Kelley BJ, Damisah E, Marks A, Hui P, DiLuna M, Vortmeyer A. Craniopharyngioma arising in a Rathke's cleft cyst: case report. Journal Of Neurosurgery Pediatrics 2015, 15: 250-4. PMID: 25555112, DOI: 10.3171/2014.11.peds14370.
- Marks A, Luo H, Chui DH, Greenberg J. Hemoglobin shady grove: A novel fetal methemoglobin variant. Pediatric Blood & Cancer 2013, 60: e55-e56. PMID: 23460588, DOI: 10.1002/pbc.24503.
- Marks AM, Packer RJ. A Review of Secondary Central Nervous System Tumors After Treatment of a Primary Pediatric Malignancy. Seminars In Pediatric Neurology 2012, 19: 43-48. PMID: 22641075, DOI: 10.1016/j.spen.2012.02.015.
- Maniscalco J, Dryer A, Marks A, Yunghans M. Index of Suspicion. Pediatrics In Review 2008, 29: 321-328. DOI: 10.1542/pir.29.9.321.
- Maniscalco J, Dryer AL, Marks A, Yunghans M, Pierson SB, Sgarlat CM, Sveen AR, Blanch LE. Index of Suspicion. Pediatrics In Review 2008, 29: 321-328. PMID: 18765471, DOI: 10.1542/pir.29-9-321.
- Yale Pediatric Hematology/OncologySmilow Cancer Hospital at Yale New Haven35 Park Street, Fl 7New Haven, CT 06511
- YNHCH Pediatric Specialty Center at TrumbullTrumbull Pediatric Specialty Center5520 Park Avenue, Ste 600Trumbull, CT 06611
- Yale Pediatric Hematology/OncologySmilow Cancer Hospital at Yale New Haven35 Park Street, Fl 7New Haven, CT 06511
- YNHCH Pediatric Specialty Center at TrumbullTrumbull Pediatric Specialty Center5520 Park Avenue, Ste 600Trumbull, CT 06611